HIIFS
NITE

Harel Insurance Investments & Financial Services’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio NITE Stock Details NITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-8,261
Closed -$169K – 551
2018
Q3 		$169K Buy
+8,261
New +$170K 0.01% 217

Other funds holding NITE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Harel Insurance Investments & Financial Services's NITE Position: Q4 2018 in Review

Harel Insurance Investments & Financial Services sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q4 2018, closing a stake of 8,261 shares — an estimated $169K sold.

Harel Insurance Investments & Financial Services first reported a position in NITE in Q3 2018 and held it in 1 quarter. The position peaked at $169K in Q3 2018. 29 funds tracked by Wall St. Rank hold NITE as of Q4 2018.

  • Harel Insurance Investments & Financial Services reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 8,261 Nightstar Therapeutics plc American Depositary Shares shares in Q4 2018, an estimated $169K.
  • Harel Insurance Investments & Financial Services first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2018 and held it in 1 quarter.
  • Harel Insurance Investments & Financial Services's Nightstar Therapeutics plc American Depositary Shares position peaked at $169K in Q3 2018.
  • 29 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q4 2018.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2018, filed 29 Jan 2019.